Peter B. Kang, MD, FAAN, FAAP, FCNS is a pediatric neuromuscular neurologist and physician-scientist whose laboratory studies the genetics and disease mechanisms of muscular dystrophy and DNA repair disorders, with the goal of discovering new therapeutic targets for these diseases.  His laboratory has particular interests in limb-girdle muscular dystrophy, rare muscle diseases associated with the Notch signaling pathway and cholesterol metabolism, and Cockayne syndrome.  He has published extensively on these subjects, has co-edited a textbook of pediatric electromyography, and has been awarded multiple grants from the NIH and the Muscular Dystrophy Association to support his investigations.  With support from the CDC, he led the successful initiation of the first site in Florida for the MD STARnet consortium and continues to work on this project.  National presentations have included lectures at the annual meetings of the American Academy of Neurology, American Academy of Pediatrics, American Association of Neuromuscular and Electrodiagnostic Medicine, the Child Neurology Society, and the Muscular Dystrophy Association. His former trainees hold faculty positions in the United States, Canada, South Korea, and Japan.  He is President of the Child Neurology Society and Editor of Neurology® Genetics.

Previously, Dr. Kang was Professor of Pediatrics, Chief of the Division of Pediatric Neurology, and Director of the Child Neurology Residency Program at the University of Florida College of Medicine. Earlier in his career, he was Director of the Electromyography Laboratory at Boston Children's Hospital and Associate Professor of Neurology at Harvard Medical School.

In clinic, Dr. Kang sees children with confirmed or suspected neuromuscular disorders such as muscular dystrophy, congenital myopathy, neuropathies, brachial plexus injuries, spinal muscular atrophy, myasthenia gravis, Charcot-Marie-Tooth disease, and other neuropathies, as well as children with DNA repair disorders such as Cockayne syndrome, trichothiodystrophy, and xeroderma pigmentosum. He will see adult patients with these conditions upon request.